T Umetsu

521 total citations
23 papers, 436 citations indexed

About

T Umetsu is a scholar working on Cardiology and Cardiovascular Medicine, Oncology and Analytical Chemistry. According to data from OpenAlex, T Umetsu has authored 23 papers receiving a total of 436 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cardiology and Cardiovascular Medicine, 5 papers in Oncology and 5 papers in Analytical Chemistry. Recurrent topics in T Umetsu's work include Antiplatelet Therapy and Cardiovascular Diseases (5 papers), Analytical Methods in Pharmaceuticals (5 papers) and Nitric Oxide and Endothelin Effects (4 papers). T Umetsu is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (5 papers), Analytical Methods in Pharmaceuticals (5 papers) and Nitric Oxide and Endothelin Effects (4 papers). T Umetsu collaborates with scholars based in Japan and United States. T Umetsu's co-authors include Kazuko Sanai, Tatsunori Murata, Shintaro Nishio, Shin‐ichi Nishio, Tetsuya Hirano, Hirotoshi Matsuura, Yoshie Tanaka, Alex Sim, Takeshi Murai and Kunio Kimura and has published in prestigious journals such as European Journal of Pharmacology, Thrombosis and Haemostasis and The Journal of Antibiotics.

In The Last Decade

T Umetsu

23 papers receiving 397 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T Umetsu Japan 10 150 96 93 89 81 23 436
Shintaro Nishio Japan 13 144 1.0× 129 1.3× 112 1.2× 80 0.9× 72 0.9× 29 437
C.M. Ingerman-Wojenski United States 9 202 1.3× 81 0.8× 113 1.2× 95 1.1× 135 1.7× 12 578
Shuichiro Hamano Japan 16 122 0.8× 103 1.1× 120 1.3× 225 2.5× 56 0.7× 34 685
M A Orchard United Kingdom 13 84 0.6× 60 0.6× 87 0.9× 205 2.3× 88 1.1× 36 606
J Kaliman Austria 13 213 1.4× 66 0.7× 58 0.6× 66 0.7× 88 1.1× 78 513
Clara Santonastaso Italy 11 199 1.3× 79 0.8× 106 1.1× 104 1.2× 83 1.0× 16 646
K Bieroń Poland 10 112 0.7× 56 0.6× 62 0.7× 52 0.6× 92 1.1× 28 364
Nahid Alavi United States 9 200 1.3× 45 0.5× 49 0.5× 147 1.7× 58 0.7× 13 582
Eric G. Spokas United States 11 89 0.6× 29 0.3× 195 2.1× 121 1.4× 95 1.2× 22 550
E Kostka-Trąbka Poland 10 85 0.6× 53 0.6× 66 0.7× 39 0.4× 68 0.8× 33 322

Countries citing papers authored by T Umetsu

Since Specialization
Citations

This map shows the geographic impact of T Umetsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T Umetsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T Umetsu more than expected).

Fields of papers citing papers by T Umetsu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T Umetsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T Umetsu. The network helps show where T Umetsu may publish in the future.

Co-authorship network of co-authors of T Umetsu

This figure shows the co-authorship network connecting the top 25 collaborators of T Umetsu. A scholar is included among the top collaborators of T Umetsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T Umetsu. T Umetsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hirano, Tetsuya, et al.. (1992). The effects of beraprost Na, a stable prostacyclin analog, on animal models of stroke. Molecular and Chemical Neuropathology. 17(1). 91–102. 6 indexed citations
2.
Murai, Takeshi, Kazuyuki Muraoka, Nobuhiro Sato, et al.. (1989). Effect of beraprost sodium on peripheral circulation insufficiency in rats and rabbits.. PubMed. 39(8). 856–9. 15 indexed citations
3.
Murata, Tatsunori, Takeshi Murai, Kazuko Sanai, et al.. (1989). General pharmacology of beraprost sodium. 2nd communication: effect on the autonomic, cardiovascular and gastrointestinal systems, and other effects.. PubMed. 39(8). 867–76. 31 indexed citations
4.
Murata, Tatsunori, et al.. (1989). General pharmacology of beraprost sodium. 1st communication: effect on the central nervous system.. PubMed. 39(8). 860–6. 5 indexed citations
5.
Nishio, Shin‐ichi, et al.. (1989). Effect of beraprost sodium (TRK-100) on acetic acid-induced skin ulcer.. PubMed. 64(3). 381–93. 2 indexed citations
6.
Umetsu, T, Tatsunori Murata, & Shin‐ichi Nishio. (1989). Studies on the antiplatelet effect of the stable epoprostenol analogue beraprost sodium and its mechanism of action in rats.. PubMed. 39(1). 68–73. 32 indexed citations
7.
Yamada, Naohiro, et al.. (1989). Effect of beraprost sodium on peripheral circulatory disturbances induced by various stimuli.. PubMed. 39(10). 1229–34. 17 indexed citations
8.
Nishio, Shintaro, Hirotoshi Matsuura, Masakazu Hattori, et al.. (1989). Cardiovascular effects of beraprost sodium (TRK-100), a prostacyclin analogue in the dog.. Folia Pharmacologica Japonica. 94(6). 351–361. 5 indexed citations
9.
Nishio, Shintaro, et al.. (1988). The in vitro and ex vivo antiplatelet effect of TRK-100, a stable prostacyclin analog, in several species.. The Japanese Journal of Pharmacology. 47(1). 1–10. 83 indexed citations
10.
Nishio, Shintaro, et al.. (1988). The In Vitro and Ex Vivo Antiplatelet Effect of TRK-100, a Stable Prostacyclin Analog, in Several Species. The Japanese Journal of Pharmacology. 47(1). 1–10. 8 indexed citations
11.
Umetsu, T, et al.. (1987). Antithrombotic Effect of TRK-100, a Novel, Stable PGI2 Analogue. The Japanese Journal of Pharmacology. 43(1). 81–90. 3 indexed citations
12.
Watanabe, Norihiro, Hiroshi Umeno, H Neda, et al.. (1987). [The synergistic effect of human recombinant TNF in combination with hyperthermia].. PubMed. 22(3). 632–7. 1 indexed citations
13.
Sim, Alex, et al.. (1985). Effect of a stable prostacyclin analogue on platelet function and experimentally-induced thrombosis in the microcirculation.. PubMed. 35(12). 1816–8. 49 indexed citations
14.
Nishio, Shintaro, et al.. (1985). Anti-platelet effects of a new PGI analog, TRK-100.. The Japanese Journal of Pharmacology. 39. 388–388. 6 indexed citations
15.
Umetsu, T, et al.. (1985). Antithrombotic effect of TRK-100, a new PGI2 analog. The Japanese Journal of Pharmacology. 39. 385–385. 1 indexed citations
16.
Umetsu, T, et al.. (1978). Effect of 1-Methyl-2-Mercapto-5-(3-Pyridyl)-Imidazole (KC-6141) on Rabbit Platelet Aggregation in Vitro and Rat Platelet Retention. Thrombosis and Haemostasis. 39(1). 167–176. 4 indexed citations
17.
Umetsu, T & Kazuko Sanai. (1978). Effect of 1-Methyl-2-Mercapto-5-(3-Pyridyl)-Imidazole (KC-6141), an Anti-Aggregating Compound, on Experimental Thrombosis in Rats. Thrombosis and Haemostasis. 39(1). 74–83. 83 indexed citations
18.
Mitani, Mitsuaki, T Umetsu, Tadashi Yamanishi, & NOBORU OTAKE. (1977). Studies on the ionophorous antibiotics. VIII. Effects of monovalent and divalent cation ionophores on blood platelets.. The Journal of Antibiotics. 30(3). 239–243. 13 indexed citations
19.
Umetsu, T, et al.. (1976). Effects of bupranolol, a new beta-blocker, on platelet functions of rabbit and human in vitro.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 36(2). 376–87. 1 indexed citations
20.
Umetsu, T, et al.. (1976). Effects of Bupranolol, a New β-Blocker, on Platelet Functions of Rabbit and Human in Vitro. Thrombosis and Haemostasis. 36(2). 376–387. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026